Russell Barrans, Chief Commercial Officer at Evofem Biosciences, Inc. (EVFM), bought 3,715 shares at $1.98 ($7K) on 2018-08-10, disclosed to the SEC on 2018-08-13.
Open-market purchase of $7k EVFM by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| EVFM | SELL | 2020-02-21 | $194K | — | Filing → |
| EVFM | SELL | 2020-01-21 | $10K | — | Filing → |
| EVFM | BUY | 2018-11-26 | $990 | — | Filing → |